InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-51.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by KOVEN ANDREW I, Director. Director active across 4 companies, notably Kala Pharmaceuticals, Inc.. In total, 8 reports have been recorded. History available since 17 June 2021. The latest transaction was disclosed on 11 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations8 total
1,750 shares0Common StockSEC:0001415889-24-016570:0
5,051 shares0Common StockSEC:0001104659-24-069786:0
87,500 shares0Common StockSEC:0001104659-23-084992:0
7,515 shares0Common StockSEC:0001415889-23-010288:0
2,197 sharesCommon StockSEC:0001415889-23-009140:0
25,000 shares0Common StockSEC:0001415889-21-003121
25,000 shares0Common StockSEC:0001415889-21-003121:0
1,476,674 sharesCommon SharesSEC:0001104659-16-095183:0
8 of 8 declarations
About KOVEN ANDREW I
Andrew I. Koven is a Board Member at Kala Pharmaceuticals, Inc. He plays a key role in overseeing the company's operations and formulating its strategy. His experience in the pharmaceutical sector is an asset for the company's development.
